Author | Cheryl Guttman Krader, BS, Pharm


PET imaging agent found superior to CT for lymph node staging in prostate cancer

August 13, 2020


Agent shows statistically significant superiority to conventional computed tomography.

Men on active surveillance for prostate cancer may benefit from Mediterranean diet

July 28, 2020


Mediterranean diet score was modestly associated with time to grade group progression.

Study reveals risk factors for upgrading in active surveillance for prostate cancer

July 27, 2020


“Our findings suggest that genomic score and PSA density are risk factors for upgrading within 3 years of commencing active surveillance,” the investigators wrote.

Rechargeable neuromodulation system safe and efficacious through 1 year

June 30, 2020


The reduction in urinary urgency incontinence episodes observed was “quite significant,” an investigator said.